Dr. Jerry Halpern, clinical assistant professor of surgery, was honored by the Chief Dental Consultant to the Office of Chief Medical Examiner of New York and the New York Society of Forensic Dentistry at the Waldorf-Astoria Hotel on Sept. 21, along with other forensic dentists, dental hygienists and dental assistants who volunteered to identify the remains of the victims of the Sept. 11th attacks. Dr. Halpern was also presented with an award at the 84th Annual Scientific Meeting of the American Association of Oral and Maxillofacial Surgeons in Chicago on Oct. 2, on behalf of all the oral and maxillofacial surgeons from New York who participated in the forensic identification team during the Sept. 11th tragedy and its aftermath.
Dr. Siskind and Dr. Lisa Staiano-Coico, senior associate dean for research, at his retirement reception held in July.
Dr. Charles Inturrisi, professor of pharmacology, was awarded a five-year renewal of a $2.1 million training grant from the National Institute on Drug Abuse. The award, which is in its 10th year and is supported by a tri-institutional faculty, provides support for five pre-doctoral trainees who receive training in the pharmacology and neuroscience of drug abuse.
Dr. Harvey Lincoff, professor emeritus of ophthalmology, delivered the 6th Annual Vitreous Society Founder's Lecture during the combined meeting of the Vitreous Society and the Retina Society on Sept. 29, in San Francisco. He received a $5,000 honorarium for his topic, "The Effect of Cutting the Encircling Band on Choroidal Flow and Visual Function."
Dr. John Moore, professor of microbiology and immunology, is the recipient of the 2002 Research in Action Award given by the New York City-based Treatment Action Group (TAG), which is committed to finding a cure for AIDS and works with various communities affected by HIV.
Dr. Carl Nathan, the R.A. Rees Pritchett Professor of Microbiology, professor of microbiology & immunology and medicine, and chairman of the Department of Microbiology and Immunology, was inducted as a fellow of the American Academy of Microbiology for his work on the high-output pathway of nitric oxide production, the biochemistry of cytokine-mediated macrophage activation and deactivation, and the enzymology of defense against reactive oxygen and nitrogen intermediates.
Dr. Maria New, head of the Division of Pediatric Endocrinology, is the recipient of the 2003 Fred Conrad Koch Award, the highest recognition in the field of endocrinology. The award provides a $25,000 honorarium and complimentary registration to the Society's Annual Meeting in Philadelphia from June 18-21, 2003. The Endocrine Society Annual Awards Dinner will be held on June 17, 2003, in Philadelphia.
Dr. Sunil Panchal, assistant professor of anesthesiology and director of the Division of Pain Medicine, chaired the 2002 annual meeting for the Eastern Pain Association on Sept. 13, at the Marriott in Manhattan, and was elected to a two-year term on the board of directors for the Eastern Pain Association.
Dr. Herbert Pardes, president and chief executive officer of NewYork-Presbyterian Hospital, was inducted as a fellow of the American Academy of Arts and Sciences in a ceremony at Sanders Theatre of Harvard University on Oct. 5. Dr. Pardes was recognized for his leadership in health care and his significant contributions to scientific research and clinical care.
Dr. Marcus Reidenberg, professor of pharmacology and medicine, was a participant in an invitation-only workshop on "Abuse Liability Assessment of CNS Active Drugs" in Bethesda, Md. from Oct. 28-29. The workshop was organized by the College on Problems of Drug Dependence and was co-sponsored by the Food and Drug Administration, the Drug Enforcement Administration and the National Institutes of Health. Dr. Reidenberg was a member of an expert panel that prepared the final conclusions and recommendations of the workshop for publication. These recommendations are in the areas of research needs and future medicinal drug development and regulation.
Dr. Richard Silver, professor of medicine and director of the Center for Leukemia and Myeloproliferative Disorders at Weill Cornell and medical director of the Cancer Research and Treatment Fund, lectured on polycythemia vera and chaired the session on myeloproliferative diseases at the 29th Congress of the International Society of Hematology held in August, in Seoul, Korea.
Dr. Siskind with two of his RASP colleagues, Dorothy Hilpmann and Carolyn Schnall.
Dr. Gregory Siskind has retired as associate dean for research and sponsored programs (RASP) at the Medical College. Dr. Siskind had served as associate dean for RASP since 1983. He came to the Medical College in 1969, when he was appointed associate professor of medicine and head of the Division of Allergy and Immunology in the Department of Medicine. He became professor of medicine in 1976. In 1983, he was asked to oversee the office of Research and Sponsored Programs. Dr. Siskind received his undergradute degree from Cornell University and his M.D. degree from New York University School of Medicine. He was honored by his colleagues and friends at a retirement reception in July. Though officially retired from RASP, he continues to do consulting work for the department.
Dr. Clemens Steegborn, postdoctoral associate in biochemistry, is a recipient of the Damon Runyon Cancer Research Foundation Fellowship Award for conducting theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies, and prevention. Dr. Steegborn received the fellowship in May at the Damon Runyon Scientific Advisory Committee review.
Dr. Hao Wu, associate professor of biochemistry, received the Margaret Oakley Dayhoff Award for 2002-2003 from the Biophysical Society. This award is presented to a junior woman scientist in a field within the range of interest of the society. The award, which is aimed toward "the woman of very high promise who has not yet reached a position of high recognition within the structures of academic society," consists of a $2,000 prize.
Dr. Roger Yurt, the Johnson & Johnson Distinguished Professor of Surgery and director of the William Randolph Hearst Burn Center, was one of the keynote speakers at the 14th Annual Burn Congress, held Oct. 16-19, at the Phoenix Airport Marriott. The World Burn Congress is an annual international gathering of burn survivors, their families, health-care providers and firefighters. The conference provides many survivors with the opportunity to discuss the challenges of a severe burn injury and experience the possibility of life after this type of trauma.